POSA108 A Budget Impact Analysis of Atezolizumab Monotherapy for First Line Treatment of Patients with PD-L1 High Metastatic NSCLC in Italy
Abstract
Authors
L Pradelli M Bellone E Heaton H Celik A Caputo M Belfiore
L Pradelli M Bellone E Heaton H Celik A Caputo M Belfiore
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now